Skip to main content
Kindstar Globalgene Technology, Inc. logo

Kindstar Globalgene Technology, Inc. — Investor Relations & Filings

Ticker · 9960 ISIN · KYG5262E1044 HKEX Human health and social work activities
Open in API
Filings indexed 602 across all filing types
Latest filing 2024-05-30 Transaction in Own Shar…
Country HK Hong Kong
Listing HKEX 9960

About Kindstar Globalgene Technology, Inc.

http://www.kindstar.com.cn

Kindstar Globalgene Technology, Inc. is a leading independent provider of advanced specialty clinical testing services, specializing in esoteric testing. The company maintains the largest esoteric testing portfolio in its market, utilizing internationally-advanced laboratory facilities for clinical testing, scientific research, and applied R&D. Its comprehensive testing menu, featuring over 100 items, covers critical diagnostic areas including hematology, genetic diseases, gynecology, infectious diseases, neurology, and oncology. These services provide physicians and patients access to specialized diagnostics crucial for the diagnosis and treatment of major diseases.

Recent filings

Filing Released Lang Actions
Next Day Disclosure Returns
Transaction in Own Shares Classification · 95% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks for Kindstar Globalgene Technology, Inc. It includes detailed data on repurchases of shares over multiple dates, confirming compliance with listing rules of the Stock Exchange of Hong Kong (SEHK). The content is focused on reporting share repurchase transactions and changes in issued share capital, which aligns with announcements regarding transactions in own shares. There is no indication of a full financial report, earnings release, or management discussion. The document is not a report publication announcement or a certification letter but a detailed disclosure of share repurchase activity. Therefore, the appropriate classification is 'Transaction in Own Shares' (POS).
2024-05-30 English
Next Day Disclosure Returns
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and is submitted by Kindstar Globalgene Technology, Inc. It details numerous entries of repurchase of shares (share buybacks) with dates and quantities, referencing compliance with the Main Board Listing Rules and GEM Listing Rules of the Stock Exchange of Hong Kong. The content is a regulatory disclosure of changes in issued share capital and share buybacks, including confirmations related to authorization and legal compliance. There are no financial statements, earnings data, or management discussion, nor is it an announcement of a report publication. The document is a formal regulatory filing reporting share repurchase transactions and capital changes. According to the filing definitions, this fits best under 'Transaction in Own Shares (POS)' which covers reports of the company buying back or selling its own shares (share repurchase/issuance).
2024-05-29 English
Next Day Disclosure Returns
Transaction in Own Shares Classification · 95% confidence The document is titled 'Next Day Disclosure Return' and pertains to changes in issued share capital and share buybacks for Kindstar Globalgene Technology, Inc. It includes detailed listings of repurchases of shares with dates and quantities, confirming it is a report on share repurchase activity. The document references compliance with listing rules of the Stock Exchange of Hong Kong and provides confirmations related to share issues and repurchases. This type of document is a report of the company buying back its own shares, which fits the category 'Transaction in Own Shares' (POS). The document length is substantial and contains detailed transactional data, not merely an announcement or a brief summary, so it is not a Regulatory Filing or Report Publication Announcement. Therefore, the correct classification is POS with high confidence.
2024-05-28 English
Next Day Disclosure Returns
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and pertains to changes in issued share capital and share buybacks for Kindstar Globalgene Technology, Inc. It includes detailed data on repurchases of shares over multiple dates, confirming compliance with listing rules of the Stock Exchange of Hong Kong. The content is a regulatory disclosure about share repurchases, not a financial report or earnings release. It is a formal notification of share capital changes and repurchases, fitting the category of Transaction in Own Shares (POS). The document length and detail confirm it is the report itself, not just an announcement of a report.
2024-05-27 English
Next Day Disclosure Returns
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks by Kindstar Globalgene Technology, Inc. It contains detailed tabular data on repurchases of shares over multiple dates, confirming compliance with listing rules of the Stock Exchange of Hong Kong. The content focuses on share repurchase activities and changes in issued shares, with no financial statements or earnings data. This matches the description of a 'Transaction in Own Shares' filing, which reports on company buybacks or sales of its own shares. The document is lengthy and detailed, not a brief announcement or certification, so it is not a Regulatory Filing or Report Publication Announcement. Therefore, the correct classification is POS (Transaction in Own Shares).
2024-05-24 English
Next Day Disclosure Returns
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks for Kindstar Globalgene Technology, Inc. It contains detailed data on repurchases of shares over multiple dates, including quantities and percentages. The document references compliance with listing rules of the Stock Exchange of Hong Kong and confirms authorization by the board of directors. The content is focused on reporting share repurchase activities, not on financial results, management changes, or other report types. This matches the definition of a 'Transaction in Own Shares' filing, which reports company buybacks or sales of its own shares. The document length is substantial and contains detailed transactional data, not just an announcement or certification, so it is not a Regulatory Filing or Report Publication Announcement. Therefore, the correct classification is POS (Transaction in Own Shares).
2024-05-23 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.